350684-49-0

Basic information

• Product Name: TERT-BUTYL 4-(4-AMINOBENZOYL)TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE
• Synonyms: TERT-BUTYL 4-(4-AMINOBENZOYL)TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE;tert-Butyl 4-(4-aMinobenzoyl)piperazine-1-carboxylate;1-Piperazinecarboxylic acid, 4-(4-aMinobenzoyl)-, 1,1-diMethylethyl ester;2-[3-Chloro-2-oxo-5-(trifluoromethyl)pyridin-1-yl]acetamide;tert-Butyl 4-(4-aminobenzoyl)tetrahydro-1(2H)-pyrazine;tert-Butyl 4-(4-aminobenzoyl);2-[3-Bromo-2-oxo-5-(trifluoromethyl)-1-pyridyl]acetamide
• CAS NO: 350684-49-0
• Molecular Formula: C₁₆H₂₃N₃O₃
• Molecular Weight: 305.37
• Mol File: 350684-49-0.mol
• Article Data: 17

Chemical Properties

• Melting Point: 159-160
• Boiling Point: 488.1±40.0 °C(Predicted)
• Appearance: /
• Density: 1 +-.0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C(protect from light)
• PKA: 3.50±0.10(Predicted)
• CAS DataBase Reference: TERT-BUTYL 4-(4-AMINOBENZOYL)TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: TERT-BUTYL 4-(4-AMINOBENZOYL)TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE(350684-49-0)
• EPA Substance Registry System: TERT-BUTYL 4-(4-AMINOBENZOYL)TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE(350684-49-0)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 350684-49-0(Hazardous Substances Data)

Usage

General Description

Tert-butyl 4-(4-aminobenzoyl)tetrahydro-1(2H)-pyrazinecarboxylate is a chemical compound that belongs to the class of organic compounds known as benzamides. It is a synthetic compound that is commonly used in pharmaceutical research and development as a potential drug candidate. TERT-BUTYL 4-(4-AMINOBENZOYL)TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE possesses several functional groups including a tert-butyl ester, an amine, and a carboxylic ester. Tert-butyl 4-(4-aminobenzoyl)tetrahydro-1(2H)-pyrazinecarboxylate has potential therapeutic applications and is currently being studied for its potential use in the treatment of various diseases and medical conditions.

Upstream product

• 150-13-0 4-amino-benzoic acid 
• 57260-71-6 1-t-Butoxycarbonylpiperazine 
• 509073-62-5 tert-butyl 4-(4-nitrobenzoyl)piperazine- 1-carboxylate 
• 62-23-7 4-nitro-benzoic acid 
• 122-04-3 4-nitro-benzoyl chloride 

Downstream Products

• 700804-69-9 N-cyano-N'-((4-(4-tert-butoxycarbonyl)piperazinocarbonyl)-phenyl)-O-phenylisourea 
• 466694-75-7 methyl 3-(Z)-[1-{4-[(4-tert-butyloxycarbonyl-piperazin-1-yl)-carbonyl]-phenylamino }-1-phenyl-methylidene]-2-indolinone-6-carboxylate 
• 372095-34-6 N-[4-(4-tert-Butoxycarbonylpiperazin-1-ylcarbonyl)phenyl]-(2-chloro-5-nitrophenyl)carboxamide 
• 72141-42-5 4-aminobenzoylpiperazine 
• 1235467-40-9 tert-butyl 4-(4-(4-bromo-2-cyanophenylamino)-benzoyl)piperazine-1-carboxylate 
• 1566584-48-2 tert-butyl 4-(4-((4-chloro-5-(trifluoromethyl) pyrimidin-2-yl)amino)benzoyl)piperazine-1-carboxylate 
• 1566584-49-3 tert-butyl 4-(4-((4-((2-(2-methoxy-2-oxoethyl)phenyl)ethynyl)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzoyl)piperazine-1-carboxylate 
• 1566584-50-6 tert-butyl 4-(4-((4-(2-(2-methoxy-2-oxoethyl)phenethyl)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzoyl)piperazine-1-carboxylate 
• 1566584-51-7 C₃₁H₃₄F₃N₅O₅ 
• 1566584-52-8 tert-butyl 4-(4-((4-(2-(2-amino-2-oxoethyl)phenethyl)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzoyl)piperazine-1-carboxylate 
• 1566583-85-4 2-(2-(2-(2-((4-(piperazine-1-carbonyl)phenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)ethyl)phenyl)acetamide 

Relevant articles and documents

Memantine urea derivative as well as preparation method and application thereof

The invention provides a memantine urea derivative as well as a preparation method and application thereof, and relates to the technical field of medicines. The memantine urea derivative provided by the invention has a typical urea structure as a primary

SMALL MOLECULE PROTEOLYSIS-TARGETING CHIMERAS AND METHODS OF USE THEREOF

Novel small molecule proteolysis-targeting chimeras (PROTACs) are provided, along with methods for their use as Bruton's tyrosine kinase (BTK) degraders. The small molecule PROTACs described herein are useful in treating and/or preventing BTK-related diseases, such as cancer, neurodegenerative disorders, inflammatory diseases, and metabolic disorders. Also provided are methods for inducing BTK degradation in a cell using the compounds and compositions described herein. Exemplary compounds include: (I).

Discovery of 2,4-diarylaminopyrimidine derivatives bearing dithiocarbamate moiety as novel FAK inhibitors with antitumor and anti-angiogenesis activities

A series of 2,4-diarylaminopyrimidine derivatives containing dithiocarbamate moiety were designed by molecular hybridization strategy and synthesized for screening as inhibitors of focal adhesion kinase (FAK). Most of these compounds exhibit significant a